Arrowhead Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
16.01.24
/
50%
€31.94
Target price
16.01.25
€45.92
Performance (%)
-26.61%
Price
09.07.24
€23.44
Summary
This prediction is currently active. The price of Arrowhead Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -26.61%. This prediction currently runs until 16.01.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Arrowhead Pharmaceuticals Inc. | -0.128% | -0.128% |
iShares Core DAX® | 0.383% | -1.593% |
iShares Nasdaq 100 | 1.543% | 7.530% |
iShares Nikkei 225® | 2.596% | 4.525% |
iShares S&P 500 | 0.573% | 4.229% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $50.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€29.40
07.02.24
07.02.24
€46.44
07.02.25
07.02.25
-20.27%
09.07.24
09.07.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€22.00
30.11.23
30.11.23
€45.85
30.11.24
30.11.24
6.55%
09.07.24
09.07.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.07
08.08.23
08.08.23
€54.74
08.08.24
08.08.24
-6.50%
09.07.24
09.07.24